Table 2 Significantly mutated genes in SMC

From: Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures

  

SMC

TCGA

SMC vs. TCGA

Gene symbol

Gene description

Mut Freq (n=186)

p value

q value

Mut Freq (n=1001)

q value

p value

TP53

tumor protein p53

89 (47.9%)

0

0

320 (32.0%)

0

2.89e-04

PIK3CA

phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha

53 (28.5%)

0

0

320 (32.0%)

2.09e-12

0.81

GATA3

GATA binding protein 3

23 (12.4%)

0

0

91 (9.1%)

0

0.49

CBFB

core-binding factor, beta subunit

5 (2.7%)

0

0

21 (2.1%)

7.85e-07

0.83

PTEN

phosphatase and tensin homolog

6 (3.2%)

6.40e-06

0.015

44 (4.4%)

0

0.83

CDH1

Cadherin-1

4 (2.2%)

3.64e-05

0.076

115 (11.5%)

8.64e-13

2.46e-04

  1. SMC has 186 WES samples and 167 tumor samples with both WES and RNA-Seq data. TCGA has 1002 WES samples. Mut Freq: number of mutated samples (% of mutated samples). p value, q value: mutation significance reported by MutSigCV. SMC vs. TCGA: Mutation prevalence were compared between SMC and TCGA by Fisher’s exact test to determine the p value